The Standard of Care: Lifestyle and Medication
At a Glance
Essential hypertension is managed with DASH eating, lower sodium, regular activity, weight management, and medication when needed. Blood pressure targets are individualized, and persistent high readings need evaluation for resistant hypertension and medication safety.
Treating essential hypertension is a lifelong commitment to protecting your heart and kidneys. The “standard of care” is a two-pronged approach that combines powerful lifestyle changes with evidence-based medications [1][2]. Depending on how high your blood pressure is and your overall cardiovascular risk, your doctor may recommend starting lifestyle changes alone first, or beginning lifestyle changes and medications at the same time [3][4].
The DASH Eating Pattern
The most studied and recommended diet for lowering blood pressure is the DASH diet (Dietary Approaches to Stop Hypertension) [5]. Unlike many diets, DASH is a balanced eating plan that focuses on:
- More of: Vegetables, fruits, whole grains, beans, nuts, and low-fat dairy [5][6].
- Less of: Saturated fats (like fatty meats and full-fat dairy), sugar-sweetened drinks, and sweets [5][7].
DASH works best when paired with a strict sodium limit. While the average person eats much more, the goal for someone with hypertension is usually less than 2,000 mg (2 grams) of sodium per day, and sometimes lower [8]. In clinical trials, combining the DASH diet with low sodium intake lowered systolic blood pressure significantly [9].
Other Vital Lifestyle Pillars
Beyond what you eat, three other habits are essential:
- Aerobic Exercise: Aim for regular physical activity, such as brisk walking, cycling, or swimming, adapted for your physical abilities [2].
- Weight Management: For those who are overweight, losing even a small amount of weight can significantly lower blood pressure [2].
- Potassium Intake: Increasing potassium through foods (like bananas and spinach) helps your body manage sodium. However, you must check with your doctor first. Kidney disease, as well as several common blood pressure medications (ACE inhibitors, ARBs, spironolactone), can cause dangerous potassium buildup (hyperkalemia). Never start potassium supplements or potassium-based “salt substitutes” without your doctor’s explicit approval.
First-Line Medication Classes
If medication is needed, your doctor will usually choose from these highly effective classes [1][10]:
- ACE Inhibitors (e.g., Lisinopril) OR ARBs (e.g., Losartan): These relax your blood vessels by blocking a system that makes them tighten. Important Safety Note: ACE inhibitors and ARBs do the same job and should never be taken together. Furthermore, they are dangerous during pregnancy and must be stopped or avoided if you are pregnant or planning to conceive.
- Calcium Channel Blockers (CCBs) (e.g., Amlodipine): These prevent calcium from entering the muscle cells of your heart and arteries, allowing them to relax [10].
- Thiazide/Thiazide-like Diuretics (e.g., Chlorthalidone, Hydrochlorothiazide): These help your kidneys remove excess salt and water from your body [1][10].
Combination Therapy
While some patients (especially those who are older, frail, or have milder elevation) start with a single drug, many guidelines recommend starting with two medications at once for many patients [4][11]. This is often prescribed as a single-pill combination—two different medications combined into one tablet. Starting with two drugs often gets blood pressure under control faster, and combining them in one pill makes it much easier to remember to take every day [12][13].
Resistant Hypertension
If your blood pressure remains uncontrolled despite taking three different types of medication at their maximum tolerated doses (and one of them is a diuretic), or if it takes four medications to control it, you may have resistant hypertension [14].
Before confirming this, your doctor will ensure you are taking your medications exactly as prescribed, verify your blood pressure is high outside the office (ruling out white-coat hypertension), and check for secondary causes. The standard “step-up” approach often involves adding a medication like spironolactone [15]. Spironolactone is very effective but can dangerously raise potassium levels; it is only used if your kidney function permits, and requires strict laboratory monitoring [16][17].
Blood Pressure Targets
Your doctor will give you a personalized blood pressure target based on your age, diabetes status, kidney health, and overall risk. While a common general target is below 130/80 mmHg, lower is not always better for everyone, especially if it causes dizziness or falls. Always work with your doctor to establish the safest target for you.
Common questions in this guide
What eating plan is recommended for essential hypertension?
What medicines are commonly used first for essential hypertension?
Could I need two blood pressure medicines instead of one?
What does resistant hypertension mean, and what happens next?
What blood pressure goal is right for me?
Is it safe to use potassium supplements or salt substitutes with blood pressure medicine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my overall cardiovascular risk, should we start with lifestyle changes alone, or a combination of lifestyle changes and medication?
- 2.Am I a candidate for a 'single-pill combination' to make it easier to stay on my medication?
- 3.What is my specific daily sodium target, and does it align with the general recommendation?
- 4.If we are starting an ACE inhibitor, ARB, or diuretic, exactly when should I get my blood tested to check my kidney function and potassium levels?
- 5.If my blood pressure remains high on my current regimen, what is our next step in checking for 'resistant hypertension'?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Targeting Hypertension: A Review on Pathophysiological Factors and Treatment Strategies.
Raj R, Garg M, Kaur A
Current hypertension reviews 2024; (20(2)):70-79 doi:10.2174/0115734021293403240309165336.
PMID: 38509679 - 2
Arterial Hypertension.
Jordan J, Kurschat C, Reuter H
Deutsches Arzteblatt international 2018; (115(33-34)):557-568.
PMID: 30189978 - 3
2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension.
Lee HY, Shin J, Kim GH, et al.
Clinical hypertension 2019; (25()):20 doi:10.1186/s40885-019-0124-x.
PMID: 31388453 - 4
Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?
Coca A, Whelton SP, Camafort M, et al.
European journal of internal medicine 2024; (126()):16-25 doi:10.1016/j.ejim.2024.04.011.
PMID: 38653633 - 5
Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.
Juraschek SP, Miller ER, Weaver CM, Appel LJ
Journal of the American College of Cardiology 2017; (70(23)):2841-2848 doi:10.1016/j.jacc.2017.10.011.
PMID: 29141784 - 6
The role of diet for prevention and management of hypertension.
Ozemek C, Laddu DR, Arena R, Lavie CJ
Current opinion in cardiology 2018; (33(4)):388-393 doi:10.1097/HCO.0000000000000532.
PMID: 29771736 - 7
2015 Evidence Analysis Library Evidence-Based Nutrition Practice Guideline for the Management of Hypertension in Adults.
Lennon SL, DellaValle DM, Rodder SG, et al.
Journal of the Academy of Nutrition and Dietetics 2017; (117(9)):1445-1458.e17 doi:10.1016/j.jand.2017.04.008.
PMID: 28578899 - 8
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
Rust P, Ekmekcioglu C
Advances in experimental medicine and biology 2017; (956()):61-84 doi:10.1007/5584_2016_147.
PMID: 27757935 - 9
Overview of salt restriction in the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean diet for blood pressure reduction.
Filippou C, Tatakis F, Polyzos D, et al.
Reviews in cardiovascular medicine 2022; (23(1)):36 doi:10.31083/j.rcm2301036.
PMID: 35092228 - 10
Hypertension.
Oparil S, Acelajado MC, Bakris GL, et al.
Nature reviews. Disease primers 2018; (4()):18014 doi:10.1038/nrdp.2018.14.
PMID: 29565029 - 11
ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison.
Bakris G, Ali W, Parati G
Journal of the American College of Cardiology 2019; (73(23)):3018-3026 doi:10.1016/j.jacc.2019.03.507.
PMID: 31196460 - 12
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.
Parati G, Kjeldsen S, Coca A, et al.
Hypertension (Dallas, Tex. : 1979) 2021; (77(2)):692-705 doi:10.1161/HYPERTENSIONAHA.120.15781.
PMID: 33390044 - 13
The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.
Du LP, Cheng ZW, Zhang YX, et al.
Journal of clinical hypertension (Greenwich, Conn.) 2018; (20(5)):902-907 doi:10.1111/jch.13272.
PMID: 29700923 - 14
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
Carey RM, Calhoun DA, Bakris GL, et al.
Hypertension (Dallas, Tex. : 1979) 2018; (72(5)):e53-e90 doi:10.1161/HYP.0000000000000084.
PMID: 30354828 - 15
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Williams B, MacDonald TM, Morant S, et al.
Lancet (London, England) 2015; (386(10008)):2059-2068 doi:10.1016/S0140-6736(15)00257-3.
PMID: 26414968 - 16
Diagnosis and Management of Resistant Hypertension: A Review.
Azizi M, Vongpatanasin W, Fisher NDL, et al.
JAMA 2026; (335(16)):1428-1439 doi:10.1001/jama.2026.1221.
PMID: 41870448 - 17
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men's Issue?
Manolis AA, Manolis TA, Melita H, Manolis AS
Current hypertension reports 2019; (21(3)):22 doi:10.1007/s11906-019-0924-0.
PMID: 30826898
This page is for informational purposes only and does not constitute medical advice. Your clinician should personalize your blood pressure target and review medications, kidney function, and potassium safety.
Get notified when new evidence is published on benign essential hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.